Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutics is Scopus-indexed (Q1, CiteScore 12.5), WoS SCIE, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 1999-4923Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 12 / 191 | 93rd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 12.5.
Pharmaceutics is Q1 in Pharmaceutical Science (rank 12 of 191), by CiteScore 2025.
Pharmaceutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.5, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.197, quartile Q1, with an H-index of 157.
The publisher lists an article processing charge of about US$3,499 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmaceutics is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 1999-4923.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Pharmaceutics has an h-index of 187 and a 2-year mean of 7.62 citations per paper (OpenAlex). Its Scopus CiteScore is 12.5, quartile Q1. On 2-year citations it ranks #9 of 177 Scopus journals in Pharmaceutical Science.
Pharmaceutics published 1,644 papers in 2025; its busiest recent year was 2022 with 2,907. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (17.9%), United States (9%) and Italy (7.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 52 retracted papers are recorded (3.5 per 1,000 papers). The Problematic Paper Screener flags 4 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.